From Nasdaq:

Medical supplies maker Patterson Cos. (PDCO) stock outperformed S&P 500 at $29.63. Shares have increased by 7.59% in the last month, compared to Medical sector’s gain of 6.57% and S&P 500’s 3.52% increase.

Patterson Cos. is expected to report a Q3 EPS of $0.61, down 1.61% from the prior year. Latest consensus estimate for revenue is $1.63 billion. Full year estimates project earnings of $2.38 per share.

Patterson Cos. falls under Zacks Rank #4 (Sell). It is trading at a Forward P/E ratio of 12.37, indicating it as undervalued compared to its industry’s P/E ratio of 21.11.

Lithium batteries will make millionaires as EV revolution expands. Investors have the chance to reach huge gains as there is an expected 889% increase in demand for lithium batteries. Download a FREE report revealing 5 EV battery stocks set to soar.



Read more: Patterson Cos. (PDCO) Surpasses Market Returns: Some Facts Worth Knowing